AdherenceCAMPSNCT01247181
Cameroon Mobile Phone SMS Trial
A study testing Mobile phone text message in people with Adherence and HIV, run by Yaounde Central Hospital at 1 site in Cameroon.
Trial summary
The investigators hypothesize that sending weekly motivational text messages to people infected with HIV will encourage them to take their medication, compared to usual care. Read more about this study
- Who is it for?
- Ages 21 to 65 years
- What is being tested?
- Mobile phone text message
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteCameroon
- Study dates
- Nov 2010to Jul 2011
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- On HAART for at least 1 month
- 21 years or more
- Owns a mobile phone
- Can read text messages
Who cannot join
- On HAART for less than 1 month
- Aged less than 21 years
Trial locations and contacts
1 site in 1 country.
Cameroon1 site
Yaounde Central Hospital Accredited Treatment Centre
Yaoundé, Centre Region
About this study
Official title: Improving Adherence to HAART Using Mobile Phone Text Messages
The investigators hypothesize that sending weekly motivational text messages to people infected with HIV will encourage them to take their medication, compared to usual care.
- Being tested
- Mobile phone text message, Usual care
- Keywords
- compliance, observance, mobile phone, SMS, text message, ARV, HAART, AIDS
- Medical subject headings
- Patient Compliance, Acquired Immunodeficiency Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mobile phone text messageOther
Also called SMS, Texto, Text message
Weekly message with motivational content
Usual careOther
Also called Routine care
Usual care provided at clinic
| Study group | Role | What they receive |
|---|---|---|
| Mobile phone text message | Experimental | Not described Receives: Other: Mobile phone text message |
| No Mobile phone text message | Active comparator | Usual care provided at clinic Receives: Other: Usual care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Adherence
Measured using the Visual Analogue Scale, Self Report and Pharmacy Refill Data
Measured: Change from baseline at 6 months
Secondary outcomes (8)
Weight
Measured: Change from baseline at 6 months
Body Mass Index
Measured: Change from baseline at 6 months
CDC classification
Measured: Change from baseline at 6 months
WHO Classification
Measured: Change from baseline at 6 months
Mortality
All cause mortality
Measured: 6 months
CD4 count
Measured: Change from baseline at 6 months
Viral load
Measured: Change from baseline at 6 months
Quality of life
Measured using the SF-12 quality of life form
Measured: Change from baseline at 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Nov 2010 (estimated)
- Study startNov 2010
- Primary completionJul 2011
- Study completionJul 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for AdherenceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Care provider, Investigator, Outcomes assessor
- Enrolment
- 200 participants (actual)
Sponsor and investigators
- Lead sponsor
- Yaounde Central Hospital
- Sponsor type
- Other government
- Collaborators
- CIHR Canadian HIV Trials Network
- Responsible party
- Principal investigator, Lawrence Mbuagbaw, Yaounde Central Hospital
- Investigators
- Lawrence Mbuagbaw, MD, MPH, Principal investigator, Centre for the Development of Best Practices in HealthPierre Ongolo-Zogo, MD, BSc, Study director, Centre for the Development of Best Practices in Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01247181
- Sponsor's protocol ID
- CAMPS
- Other IDs
- PACTR201011000261458
- Acronym
- CAMPS
- Status last verified
- Sep 2011
- First submitted
- 22 Nov 2010
- Last updated
- 8 Sep 2011
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills EJ, Smieja M, Dolovich L, Kouanfack C. The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS One. 2012;7(12):e46909. doi: 10.1371/journal.pone.0046909. Epub 2012 Dec 6.
PubMed 23236345Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills E, Volmink J, Yondo D, Essi MJ, Bonono-Momnougui RC, Mba R, Ndongo JS, Nkoa FC, Ondoa HA. The Cameroon mobile phone SMS (CAMPS) trial: a protocol for a randomized controlled trial of mobile phone text messaging versus usual care for improving adherence to highly active anti-retroviral therapy. Trials. 2011 Jan 7;12:5. doi: 10.1186/1745-6215-12-5.
PubMed 21211064
Study at a glance
From the registry record, last updated by the sponsor on 8 Sep 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Improving Adherence to HAART Using Mobile Phone Text Messages
- ClinicalTrials.gov ID
- NCT01247181
- Acronym / sponsor ID
- CAMPS / CAMPS
- Keywords
- compliance, observance, mobile phone, SMS, text message, ARV, HAART, AIDS
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 200 participants (actual)
- Lead sponsor
- Yaounde Central HospitalOther government
- Collaborators
- CIHR Canadian HIV Trials Network
- Study start
- Nov 2010
- Primary completion
- Jul 2011 (actual)
- Study completion
- Jul 2011 (actual)
- First posted
- 24 Nov 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The investigators hypothesize that sending weekly motivational text messages to people infected with HIV will encourage them to take their medication, compared to usual care.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Mobile phone text message | Experimental | Other: Mobile phone text message |
| No Mobile phone text message | Active comparator | Other: Usual careUsual care provided at clinic |
Who may qualify
- Ages
- 21 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- On HAART for at least 1 month
- 21 years or more
- Owns a mobile phone
- Can read text messages
Key exclusion criteria (2 listed)
- On HAART for less than 1 month
- Aged less than 21 years
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mobile phone text messageAlso: SMS, Texto, Text messageWeekly message with motivational content | Other | Mobile phone text message |
| Usual careAlso: Routine careUsual care provided at clinic | Other | No Mobile phone text message |
Primary outcome
Adherence
Time frame: Change from baseline at 6 months
Measured using the Visual Analogue Scale, Self Report and Pharmacy Refill Data
8 secondary outcomes
Weight
Time frame: Change from baseline at 6 months
Body Mass Index
Time frame: Change from baseline at 6 months
CDC classification
Time frame: Change from baseline at 6 months
WHO Classification
Time frame: Change from baseline at 6 months
Mortality
Time frame: 6 months
CD4 count
Time frame: Change from baseline at 6 months
Viral load
Time frame: Change from baseline at 6 months
Quality of life
Time frame: Change from baseline at 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Sep 2011.
- Derived from this study: PubMed 23236345Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills EJ, Smieja M, Dolovich L, Kouanfack C. The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS One. 2012;7(12):e46909. doi: 10.1371/journal.pone.0046909. Epub 2012 Dec 6.
- Derived from this study: PubMed 21211064Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills E, Volmink J, Yondo D, Essi MJ, Bonono-Momnougui RC, Mba R, Ndongo JS, Nkoa FC, Ondoa HA. The Cameroon mobile phone SMS (CAMPS) trial: a protocol for a randomized controlled trial of mobile phone text messaging versus usual care for improving adherence to highly active anti-retroviral therapy. Trials. 2011 Jan 7;12:5. doi: 10.1186/1745-6215-12-5.
Related trials for Adherence
Not yet recruiting
Evaluation of the Axomove Therapy Medical Device to Facilitate Adapted Physical Activity for Patients With Obesity
Obese Adults
Not yet recruitingObservational study
Daily Cognitive Failures and Medication Adherence in Fibromyalgia
Fibromyalgia
Active, not recruitingPhase 3
PREVENT HPV -Related Cancers Trial
HPV Vaccination, Uptake Vaccination
Active, not recruitingPhase 3
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia
Breast Cancer, Arthralgia
RecruitingObservational study
Patient Satisfaction Following Multidisciplinary Cancer Care Assessment in Day Hospital.
Patient Satisfaction, Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Lawrence Mbuagbaw, MD, MPH principal investigator
Centre for the Development of Best Practices in Health
Pierre Ongolo-Zogo, MD, BSc study director
Centre for the Development of Best Practices in Health
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mobile phone text message in people with Adherence and HIV, run by Yaounde Central Hospital at 1 site in Cameroon.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Sep 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Cameroon. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Adherence (time frame: Change from baseline at 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01247181, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2011.